-- Artificial Insemination is a treatment for infertility. It is a medical process involving introduction of semen into the female reproductive tract. It is recommended to the couples experiencing unexplained infertility or problem with intercourse. Artificial insemination has grown in popularity as infertility becomes more prevalent and as more women opt to become single mothers. The procedures for artificial insemination are legal in most of the developed countries but there are no such rules and regulations governing it.
Changing lifestyle, poor reproductive health of women, psychological stress, addiction, lifestyle changes and increase in age of women at the time of first pregnancy act as drives for the growth of this market. Global Market of Artificial Insemination is expected to reach USD 1.95 billion in 2023 from USD 1.35 billion in 2016 with a CAGR of approximately 10.9% during the forecast period 2017-2023.
Artificial Insemination Market - Competitive Analysis
Innovation is the organic strategy to gain the market. Many companies are operating in the market; however, the major companies dominated the major share in the market due to well-developed brand identity. Now-a-days, there is a significant increase in the number of the company offering artificial Insemination. Thus, companies are adopting the new strategies to minimize the competition and increase the market. Some major companies are focusing on development of new and advanced products to gain the market share. Whereas, some are having used the technique of acquisition and collaboration to gain the market.
Key Players:
Labotect GmbH (Germany), Hamilton Throne Ltd. (U.S.), Microtech IVF S.R.O. (Czech Republic), Rinovum Women's Health LLC (US), Zander scientific Inc. (U.S.), INVO Bioscience (U.S.), Nikon Instruments Inc. (U.S.), MedGyn products Inc. (U.S.),Conceivex Inc. (US), Biogenics Inc. (U.S.), LifeGlobal Group LLC (U.S.), TenderNeeds Fertility (US) and Surelife Pte Ltd. (Singapore).
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/1218
Artificial Insemination Market - Segmentation
Global artificial insemination market has been segmented on the basis of type of procedure which includes intracervical insemination, intrauterine insemination, intratubal insemination and other procedures. End users are hospitals, clinics, fertility centers and others.
Latest Industry Updates:
Being a competitive market, several different manufacturers are focusing on the product launch, and acquisition for the market development. Some of the latest development in the market are-
Labotect GmbH is a major player in artificial insemination market. The company develops products for use in assisted reproduction, medical science laboratories and medical surgery. Incubation technique is one of the key areas of the company helping it to maintain competitive advantage. Its products include embryo transfer catheters and puncture needle are the products for artificial insemination.
Hamilton Throne Ltd. Is a leading provider for computer aided sperm analysis and advanced laser system IVOS, CEROS, human motility II are sperm analysis products In September 2016, the company acquired Embryotech Laboratories, a company providing testing assays and quality control Services
Artificial Insemination Market - Regional Analysis
Depending on geographic region, artificial insemination market is segmented into four key regions: Americas, Europe, Asia-Pacific and Middle East and Africa. North America is the largest market. The cost of artificial insemination in America in between USD 300 to USD 500 per attempt. According to American Society of Reproductive Health, the typical success rate is 10 to 20 percent. Continuous increasing in number of fertility clinics in the U.S and Canada, increase in drug addiction and smoking among women, unprotected sexual intercourse and rising trend of planned pregnancy favor the growth of this market in America. The European market is also growing continuously.
Deterioration of reproductive health among women, increased age of women at the time of pregnancy, rising income of families and demand of technological advancement in artificial insemination drive this market in Europe. Asia-Pacific market is expected to show fastest growth in the Artificial insemination market during the forecasted period. Rise in number of miscarriages, lack of awareness about reproductive health, increase in psychological and physical stress favor the growth of this market in Asia-Pacific. Government of India has number of programs for women in rural areas. In India, Janani Suraksha Yogana under National Health Mission was a great success initiating women to carry out institution delivery which provided cash assistance to pregnant women after delivery. Middle East and Africa show steady growth in this market.
Browse Complete 80 Pages Premium Research Report Enabled with Tables and Figures @ https://www.marketresearchfuture.com/reports/artificial-insemination-market-1218
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact Info:
Name: Market Research Future
Email: Send Email
Organization: Market Research Future
Address: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune – 411028 Maharashtra, India
Phone: +1 646 845 9312
Website: https://www.marketresearchfuture.com/reports/artificial-insemination-market-1218
Release ID: 482548
Google
RSS